Airain Ltd’s Biocept, Inc. BIOC Stock Holding History

Airain Ltd’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1	Closed	-$48K	–	1097
2015 Q3	$48K	Buy	+1	New	+$62.5K	﹤0.01%	793

Other funds holding BIOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GBA

Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Callan Capital La Jolla, California $1.35B AUM 8.35% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Airain Ltd's BIOC Position: Q4 2015 in Review

Airain Ltd sold out of Biocept, Inc. (BIOC) in Q4 2015, closing a stake of 1 share — an estimated $48K sold.

Airain Ltd first reported a position in BIOC in Q3 2015 and held it in 1 quarter. The position peaked at $48K in Q3 2015. 12 funds tracked by Wall St. Rank hold BIOC as of Q4 2015.

Airain Ltd reported no remaining Biocept, Inc. position as of Q4 2015 after selling out during the quarter.
Airain Ltd sold 1 Biocept, Inc. share in Q4 2015, an estimated $48K.
Airain Ltd first reported a position in Biocept, Inc. in Q3 2015 and held it in 1 quarter.
Airain Ltd's Biocept, Inc. position peaked at $48K in Q3 2015.
12 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2015.

Based on Airain Ltd's 13F filing for Q4 2015, filed 11 Feb 2016.